Financials

News Ideas Technicals

7595 fundamentals

Overview Statements Statistics Dividends Earnings Revenue

An in-depth look to PHARMIGENE INC operating, investing, and financing activities

7595 free cash flow for H2 23 is -45.14 M TWD. For 2023, 7595 free cash flow was -717.55 M TWD and operating cash flow was -52.24 M TWD.

‪0.00‬

Cash from operating activities

Cash from investing activities

Cash from financing activities

Income statement Balance sheet Cash flow

Currency: TWD

TTM

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—